About us
Home · About us ·
About us


Since 2007

CF PharmTech was founded in Jiangsu Province in 2007.

We focus on the field of respiratory diseases and have developed into a professional pharmaceutical company focused on the international market, integrating research and development, production and sales.

Our History
  • 2022
    Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray(ShuFieMin ®) was approved for marketing.
  • 2021
    Budesonide Suspension for Inhalation(ChangQi ®) and Salbutamol Sulfate Inhalation Solution (ChangShu ®) were approved for marketing.
  • 2020
    Completed the F round of financing.
  • 2019
    Completed the E round of financing.
  • 2017
    Completed the D round of financing.
  • 2015
    Completed the C round of financing, started the construction of inhalation preparation production line and submitted the ANDA.
  • 2013
    Completed the B round of financing and established the Suzhou Changfeng Pharmaceutical.
  • 2010
    Completed the A round of financing and established the research and development center in Wuxi.
  • 2007
    CF PharmTech was founded.